Found 19 matching trials
A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects PHASE4 An open label study to evaluate an interaction between maraviroc and ralteg...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen PHASE2 The goal of this clinical study is to learn more about the effects of switc...
Show More Status
Active Not Recruiting
Location
Be Well Medical Center
Learn More & Join Trial
THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC PHASE1 This will be an open-label, parallel group, multiple dose study in approxim...
Show More Location
Pfizer New Haven Clinical Research Unit
Learn More & Join Trial
A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects PHASE1 First in human study to evaluate the safety, tolerability, and pharmacokine...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects PHASE1 The purpose of this study is to determine the effect that telaprevir and bo...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... PHASE1 Background:
People living with HIV(PLWH) are at a higher risk for cancers ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects PHASE1 This is will be an open-label, fixed-sequence, multiple dose crossover stud...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus PHASE2 To investigate the effects of food and dose regimen on the antiviral effect...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) PHASE2 Acute Graft-versus-Host-Disease (GVHD) is an important cause of morbidity a...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients PHASE4 The purpose of this proof of concept, pilot study is to determine whether t...
Show More Location
Institute of human virology
Learn More & Join Trial